Effect of bevacizumab and everolimus combination treatment on peritoneal sclerosis in an experimental rat model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of bevacizumab and everolimus combination treatment on peritoneal sclerosis in an experimental rat model

Published:2020-08-19 Issue:3 Volume:25 Page:323-330
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:Ther Apher Dial

Author:

Acıkgoz Mert Gizem Sultan¹,Ceri Mevlut²^ORCID,Calli Demirkan Nese³,Sahin Barbaros⁴,Mert Mehmet¹,Dursun Belda²

Affiliation:

1. Department of Internal Medicine Pamukkale University Faculty of Medicine Denizli Turkey

2. Department of Nephrology Pamukkale University Faculty of Medicine Denizli Turkey

3. Department of Pathology Pamukkale University Faculty of Medicine Denizli Turkey

4. Department of Experimental Surgery Application and Research Pamukkale University Faculty of Medicine Denizli Turkey

Publisher

Wiley

Subject

Nephrology,Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1744-9987.13565

Reference21 articles.

1. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: A report of the Japanese Sclerosing Encapsulating Peritonitis Study Group

2. Encapsulating Peritoneal Sclerosis: Pathophysiology and Current Treatment Options

3. 30 years of peritoneal dialysis development: The past and the future;Krediet RT;Perit Dial Int,2007

4. Encapsulating Peritoneal Sclerosis: What Have We Learned?

5. Does Immunosuppressive Treatment Ameliorate Morphology Changes in Encapsulating Peritoneal Sclerosis?

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Treatment of HPV16-positive and -negative SCC Cells With Small Molecule Tyrosine Kinase Inhibitors and Everolimus Affects MMP2 and MMP14 Expression;Anticancer Research;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3